ClinicalTrials.gg
CompletedNCT02878265Updated Aug 25, 2016

The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian Children

A Phase 3 interventional study of Vitamin A and Vitamin A and ZInc in Malaria, sponsored by University of Ghana. Completed at 1 site in Ghana. Open to female participants. Per ClinicalTrials.gov, last updated 2016-08-25.

Sponsored by University of Ghana · Phase 3, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
547
Allocation
Randomized
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 59 studies in Malaria with a site in Ghana — 5 open to participants now, 6 under way, none of them phase 3. Malaria · Ghana.

Enrollment
31st of 47
547 · median 1,490
Started
2011
with 5 others
Phase 3
13 of 59
none open now
Registered
44th of 59
by date
Lead sponsor
2 of 59
University of Ghana

Among the 59 studies in Malaria with a site in Ghana, this one is the 31st largest by enrollment of the 47 interventional ones that give a count, is one of 6 that started in 2011, is one of 13 in phase 3, and was the 44th registered.

Malaria

1,187 studies on the registry are indexed under Malaria; 80 are open to participants now.

Browse Malaria studies →

Open to participants now

5 of the 59 studies in Malaria with a site in Ghana are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Ghana have not opened yet or have stopped. Only those recruiting at a site in Ghana →

Who these studies take

Of the 51 Malaria studies recruiting now, 15 (29%) set no upper age limit and 33 (65%) stop at 75 or younger; 37 take children under 18; 31 take healthy volunteers.

This study: female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Malaria with a site in Ghana, or all of them as a file.
02

Study summary

The aim of this study was to determine the effect of combining vitamin A (VA), zinc (Z) and multivitamins (MV- A, B1, B2, B6, B12, C, D and E) on malaria morbidity

Read the detailed description

A total of 542 children aged between 6-59 months received either: (i) VA (control) or (ii) VA \& Z (VAZ) or (iii) VA, Z \& MV (VAZM). VA was delivered as a single dose while MV and Z were delivered daily. Malaria cases were managed by community health workers, who used rapid diagnostic test to confirm infection prior to treatment.

03

Conditions studied

  • Malaria

Browse trials for

Keywords

  • malaria
  • vitamin A
  • Zinc
  • Multivitamin
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • under 5years
  • will stay in the community for 10years

Exclusion criteria

Exclusion Criteria:

  • chronic diseases
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
547 participants (actual)

Study arms

  • Placebo comparator
    Vitamin A

    A single dose of 20,000IU Vitamin A for the whole study period

    Dietary Supplement: Vitamin A

  • Active comparator
    Vitamin A and zinc

    A single dose of 20,000IU Vitamin A and 10mg of elemental zinc each day for 5 months

    Dietary Supplement: Vitamin A and ZInc

  • Active comparator
    Vitamin A , Zinc and Multivitamin

    A single dose of 20,000IU Vitamin A , 10mg of elemental zinc each day and 0.5ml/kg multivitamin syrup for 5 months

    Dietary Supplement: Vitamin A , Zinc and Multivitamin

Interventions

06

What researchers measure

Primary outcomes

  1. Incidence of clinical malaria attacks

    While taking the supplement, malaria incidence will be measured

    Time frame: Baseline and every month up to six months

Secondary outcomes

  1. Incidence of diarrhea attacks

    While taking the supplement, diarrhea incidence will be measured

    Time frame: Every month up to six months

07

Study locations

1 site
  • Amoako
    Accra, 233, Ghana
08

References and documents

Publications

  • Veenemans J, Milligan P, Prentice AM, Schouten LR, Inja N, van der Heijden AC, de Boer LC, Jansen EJ, Koopmans AE, Enthoven WT, Kraaijenhagen RJ, Demir AY, Uges DR, Mbugi EV, Savelkoul HF, Verhoef H. Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: a randomised trial. PLoS Med. 2011 Nov;8(11):e1001125. doi: 10.1371/journal.pmed.1001125. Epub 2011 Nov 22. PubMed 22131908 ↗
  • Zeba AN, Sorgho H, Rouamba N, Zongo I, Rouamba J, Guiguemde RT, Hamer DH, Mokhtar N, Ouedraogo JB. Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trial. Nutr J. 2008 Jan 31;7:7. doi: 10.1186/1475-2891-7-7. PubMed 18237394 ↗
  • Owusu-Agyei S, Newton S, Mahama E, Febir LG, Ali M, Adjei K, Tchum K, Alhassan L, Moleah T, Tanumihardjo SA. Impact of vitamin A with zinc supplementation on malaria morbidity in Ghana. Nutr J. 2013 Sep 23;12:131. doi: 10.1186/1475-2891-12-131. PubMed 24330422 ↗
  • Imdad A, Herzer K, Mayo-Wilson E, Yakoob MY, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008524. doi: 10.1002/14651858.CD008524.pub2. PubMed 21154399 ↗

Individual participant data

Plan to share: Yes — To meet the participants and explain the results of their data to them

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2011, a primary completion of May 2012 and a completion of Dec 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 16, 2016
First posted
Aug 25, 2016
Start
Nov 2011
Primary completionActual
May 2012
CompletionActual
Dec 2012
Last update
Aug 25, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02878265
Lead sponsor
University of Ghana
Collaborators
Kwame Nkrumah University of Science and Technology
Responsible party
Wilhelmina Annie Mensah (Ms, University of Ghana) — Principal investigator
First posted
Aug 25, 2016
Start date
Nov 2011
Primary completion
May 2012
Completion
Dec 2012
Last update
Aug 25, 2016

Study contacts

Patricia k Brown, PhD
study chair · Kwame Nkrumah Univeristy of Science and Technolgy
Wilhelmina A Mensah, Mphil
principal investigator · University of Ghana

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Vitamin A · Zinc · Geritol

Start the discussion